Ekso Bionics to Report Third Quarter 2021 Financial Results on November 2, 2021

Rhea-AI Summary

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) will release its financial and business results for Q3 2021 on November 2, after market close. Management will discuss these results in a conference call at 1:30 p.m. PT/4:30 p.m. ET. A live webcast will be accessible in the 'Investors' section on the company's website. For those unable to attend, a replay will be available for two weeks. Ekso Bionics specializes in exoskeleton solutions for medical and industrial applications, enhancing strength and mobility for users.

Positive

• Scheduled Q3 2021 results announcement, indicating ongoing business activity.

Negative

• None.

RICHMOND, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2021 after the close of trading on Tuesday, November 2, 2021. Management will host a conference call beginning at 1:30 p.m. PT, 4:30 p.m. ET to discuss the financial results and recent business developments.

A live webcast of the event will be available in the “Investors” section of the Company’s website at www.eksobionics.com, or by clicking here. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers.

A replay of the call will be available for two weeks by dialing 877-660-6853 for domestic callers or 201-612-7415 for international callers and using Conference ID: 13723545. The webcast will also be available on the Company’s website for one month following the completion of the call.

About Ekso Bionics^® 
Ekso Bionics^® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. Ekso Bionics is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.

Investor Contact:
David Carey
212-867-1768
investors@eksobionics.com

FAQ

When will Ekso Bionics release its Q3 2021 financial results?

Ekso Bionics will release its Q3 2021 financial results on November 2, 2021, after market close.

What time is the Ekso Bionics conference call for Q3 results?

The conference call will begin at 1:30 p.m. PT / 4:30 p.m. ET on November 2, 2021.

Where can I access the Ekso Bionics Q3 results webcast?

The webcast will be available in the 'Investors' section of Ekso Bionics' website.

How can I participate in the Ekso Bionics conference call?

You can participate by calling 877-407-3036 (domestic) or 201-378-4919 (international).

Will there be a replay of the Ekso Bionics conference call?

Yes, a replay will be available for two weeks after the call by dialing 877-660-6853 (domestic) or 201-612-7415 (international).